---
document_datetime: 2023-09-21 22:07:45
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/opzelura-epar-all-authorised-presentations_en.pdf
document_name: opzelura-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7918275
conversion_datetime: 2025-12-20 13:01:41.793002
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size   |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|---------------------------|-------------|
| EU/1/23/1726/001 | Opzelura          | 15 mg/g    | Cream                 | Cutaneous use             | tube (alu)            | 100 g                     | 1 tube      |
| EU/1/23/1726/002 | Opzelura          | 15 mg/g    | Cream                 | Cutaneous use             | tube (laminate)       | 100 g                     | 1 tube      |